Summary: A clinical tria has challenged a long-held belief in stroke rehabilitation: that “more is better” in the immediate aftermath of an injury. The ESPRESSO (Enhancing Spontaneous Recovery after Stroke) trial found that providing 90 minutes of high-intensity hand and arm therapy daily—starting within just two weeks of a stroke—did not improve recovery outcomes compared to standard care.
Whether patients used an immersive, video-game-based digital platform or conventional therapy, their recovery followed a strikingly consistent biological pattern. The findings suggest that early recovery is driven by powerful, natural “biological repair” processes that aren’t necessarily accelerated by pushing patients harder during the acute phase.
Key Facts
- The “Biological Ceiling”: Researchers found that early recovery is dominated by spontaneous brain reorganization and the resolution of acute injury, which may have a natural limit that extra physical activity cannot bypass.
- The ESPRESSO Trial: 64 stroke survivors received an extra 90 minutes of therapy per day for 15 days. Despite the massive dose of extra work, their results at three months were identical to those receiving standard care.
- Biomarker Precision: In a world-first, patients were selected based on a specific biomarker linked to their recovery potential, ensuring the study measured true therapeutic impact rather than just varying levels of initial injury.
- Digital vs. Conventional: The study showed that high-tech video games (guiding aquatic creatures like dolphins) were just as effective—and more enjoyable—than conventional therapy, though neither outperformed the “natural” recovery rate in the early weeks.
Source: University of Auckland
A clinical trial led by University of Auckland researchers found that high-intensity therapy for patients begun within two weeks of a stroke did not improve hand and arm recovery beyond standard care.
Targeting new treatments to promote hand and arm recovery is necessary because persistent hand weakness is known to reduce a person’s independence at six months after stroke.
The findings, published in the journal Brain Communications, challenge the idea that “more therapy, earlier” will lead to better outcomes.
The ESPRESSo (Enhancing Spontaneous Recovery after Stroke) trial compared the effects of three weeks of daily high-repetition and high-intensity hand and arm therapies, starting within two weeks of stroke.
In a world-first for a rehabilitation trial, patients were selected based on a key biomarker that is linked to their potential for hand and arm recovery, despite the initial severity of their symptoms.
One group received the extra therapy by interacting with an immersive videogame-based digital platform which teases out a high volume of exploratory hand and arm movements that guide an animated dolphin, orca or other aquatic creature, through different levels of game play.
The other group received a time-matched dose of additional conventional therapy. Despite having access to an extra 90 minutes of therapy each day for fifteen days, neither group did better than a cohort who received standard care alone.
“We saw substantial recovery in almost all patients, but without any benefit of having extra therapy,” said Professor Winston Byblow, the University of Auckland neuroscientist who led the study.
The extra-therapy patients improved markedly between the study onset and when the additional therapy ended, with further and smaller gains at three months (the study primary endpoint). However, the three month outcomes were the same as a previous cohort treated at the same centre, who received only standard therapy.
“Our findings suggest that early recovery after stroke is dominated by powerful biological repair processes, and increasing therapy dose over and above standard care very early after stroke, may not enhance those processes,” said Byblow.
Understanding spontaneous recovery
Stroke recovery typically unfolds in phases. The first weeks are characterised by spontaneous biological recovery, driven by changes in brain excitability, reorganisation of neural circuits, and resolution of acute injury effects.
The ESPRESSo trial was prompted by the dramatic improvements often seen in animal studies when therapy doses and intensities are much higher than patients routinely experience.
For the patients as whole, recovery followed a strikingly consistent pattern regardless of the therapy type or extra therapy.
“This tells us that natural biological processes dominate recovery in the early phase after stroke,” said Byblow.
“This doesn’t mean rehabilitation isn’t important, it most certainly is, but the timing, dose, and a patient’s capacity to engage in therapy at the very early stage matter more than previously appreciated,” he said. “It is interesting to see that extra therapy can be delivered by using digital aids that are fun, engaging and rated as enjoyable by patients, with the same outcomes achieved as conventional therapy.”
Implications for stroke care
The results have important implications for how stroke rehabilitation services are organised.
Delivering intensive therapy very early after stroke is challenging, even in well‑resourced hospitals such as the one where the trial was conducted. Patients are often fatigued, medically unstable, and juggling multiple rehabilitation priorities.
The study suggests that very high‑dose therapy may be more effective later, once patients are able to engage more fully, albeit when gains are smaller.
“We may need to explore more biological treatments early rather than pushing patients harder with activity-based therapies alone. The activity-based therapy dose can be gradually increased over time,” Byblow said.
“The biggest gains from intensive training may come after early spontaneous recovery has run its course.”
About the study
The ESPRESSo trial was a single‑site, randomised, assessor‑blinded Phase IIa clinical trial conducted at Auckland City Hospital between 2021 and 2024. Sixty‑four stroke survivors were randomly assigned to either video game-based exploratory movement therapy or conventional therapy, alongside experienced therapists for 90 minutes per weekday over three weeks, in addition to usual care.
The study was funded by the Health Research Council of New Zealand.
The study was led by Professor Winston D. Byblow, School of Exercise, Sport and Rehabilitation Sciences, University of Auckland. The international research team included collaborators from Johns Hopkins University, New York Medical College, UCLA, the University of Adelaide, and MindMaze SA (Switzerland).
Key Questions Answered:
A: Absolutely not. Rehabilitation is vital. However, this study suggests that in the very early “acute” stage (the first two weeks), the brain is busy doing its own heavy lifting. Pushing a patient too hard while they are fatigued and medically unstable doesn’t seem to add extra benefits. The “big gains” from intensive training likely happen after this early natural healing phase.
A: The good news is they worked just as well and were rated as much more fun. While they didn’t speed up the “biological clock” of the brain, they proved that digital aids are a viable, engaging way to deliver therapy without losing any effectiveness compared to traditional methods.
A: Standard care is still essential. This study looked at extra high-intensity therapy on top of what is normally provided. The takeaway for doctors is that we might need to focus on “biological treatments” (like medication or non-invasive stimulation) early on, and save the high-intensity physical “boot camp” for a few weeks later when the brain is ready to engage more fully.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neurology and stroke research news
Author: Paul Panckhurst
Source: University of Auckland
Contact: Paul Panckhurst – University of Auckland
Image: The image is credited to Neuroscience News
Original Research: The findings will appear in Brain Communications
